L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum

L-dopa remains the mainstay treatment for Parkinson's disease (PD), although in later stages, treatment is complicated by L-dopa-induced dyskinesias (LID). Current evidence links LID to excessive striatal L-dopa-derived dopamine (DA) release, while the possibility of a direct involvement of L-d...

Descripción completa

Detalles Bibliográficos
Autores principales: Porras, Gregory, De Deurwaerdere, Philippe, Li, Qin, Marti, Matteo, Morgenstern, Rudolf, Sohr, Reinhard, Bezard, Erwan, Morari, Michele, Meissner, Wassilios G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893648/
https://www.ncbi.nlm.nih.gov/pubmed/24429495
http://dx.doi.org/10.1038/srep03730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893648/
https://www.ncbi.nlm.nih.gov/pubmed/24429495
http://dx.doi.org/10.1038/srep03730

Ejemplares similares